A multicenter study on rates and risk factors of proliferative vitreoretinopathy in a low-income economy
Previous reports of PVR rates in Nigerians may have been underestimated. A multi-pronged approach, including research into adjuvant pharmacotherapy, can reduce PVR rates and improve treatment outcomes.
Authors
- Wilson Ovienria (ORCID: https://orcid.org/0000-0002-2532-7099)
- Ogugua Ndubuisi Okonkwo (ORCID: https://orcid.org/0000-0002-6805-2427)
- Idris Oyekunle
- Chineze Thelma Agweye (ORCID: https://orcid.org/0000-0001-7891-4177)
- OlukoredeO Adenuga (ORCID: https://orcid.org/0000-0001-6957-4377)
- Affiong Ibanga (ORCID: https://orcid.org/0000-0003-0015-9460)
- Toyin Akanbi
- Martha-Mary Udoh
- Dennis Nkanga
Institutions
- Lagos University Teaching Hospital (NG)
- University of Calabar (NG)
- University of Uyo Teaching Hospital (NG)
- Jos University Teaching Hospital (NG)
- Irrua Specialist Teaching Hospital (NG)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-07-24
- DOI
- https://doi.org/10.1371/journal.pone.0316058
- Primary Topic
- Retinal and Macular Surgery
- Type
- article
- Field-Weighted Citation Impact
- 0.00